Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Generics Leaders Divided On Value Of Joint Procurement

Politico Panel Discussed Inflation Impact On Off-Patent Industry

Executive Summary

European healthcare leaders debated the usefulness of joint procurement and state aid for the generics and biosimilars companies at a recent Politico panel, in light of rising inflation across the continent.

You may also be interested in...



Medicines For Europe Continues To Rally For Security Of Supply

Medicines for Europe has expressed its support for a non-paper already adhered to by 21 EU member states, which proposes a number of solutions which could improve security of supply for medicines in the region.

‘Main Issue’ Facing Generics Security Of Supply Is Price, Politico Panel Hears

Panelists discussed the issues jeopardizing generics security of supply, the potential impact of pricing changes and international best practice at a recent Politico event.

New EU Rules Imminent On Joint Procurement Of Vaccines & Drugs In Health Crises

EU legislation just approved by legislators will require the European Commission to provide information on prices, manufacturers, delivery time frames and joint procurement processes for vaccines and medicines used in tackling future health crises such as pandemics.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

GB152229

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel